1. Introduction {#sec1}
===============

Stroke is the fourth leading cause of death worldwide \[[@B1]\]. Among its various etiologies, carotid stenosis is the most well observed and accounts for 30 to 35 percent of total ischemic strokes \[[@B2]\]. Stenosis grading exceeding 70% lumen reduction doubles or triples the risk of stroke and its recurrence. Vascular neurologists have reported that prompt management of carotid stenosis through standard carotid stenting prevents stroke and its recurrence. In the prestenting phase, doctors routinely administer computed tomography (CT) perfusion scans to study the cerebral blood perfusion condition in the bilateral cerebral hemispheres.

Although CT perfusion scanning has several advantages and has been recognized as a standard tool for assessing cerebral perfusion in patients undergoing stenting, not all patients can tolerate it. This neuroimaging tool entails the use of a contrast medium, which is hazardous to patients, especially those with impaired renal function.

Extracranial carotid ultrasounding is noninvasive and requires no contrast mediums. Investigation and validation of the role of ultrasound in evaluating flow conditions in pre- and poststenting phases are yet to be reported in the literature. This study utilizes a clinical parameter---resistance index (RI)---generated through carotid ultrasound exams and CT perfusion scans to investigate whether flow changes can be simultaneously observed in these two examinations.

2. Materials and Methods {#sec2}
========================

2.1. Patient Identification {#sec2.1}
---------------------------

We consecutively recruited 15 patients scheduled to undergo carotid stenting. The patients were admitted to our outpatient clinics and emergency departments or transferred from our branch hospital; all patients had been hospitalized for examination and treatment. We included patients with age ≥18 years, with an initial ischemic or recurrent strokes, with angiographic evidence of \>70% carotid stenosis, with no other etiology of stroke that could explain the index event, and with no evidence of recurrent stroke during the study period and followed up at least 6 months after the stenting treatment. Exclusion criteria were patients with cerebral hemorrhage, cerebral arteriovenous malformations, aneurysms, and bilateral moderate-severe carotid stenosis, and less than 6 months\' follow-ups. The enrolled patients were hospitalized for medical treatments along with baseline biochemistry work-ups. The ischemic stroke was confirmed by the diffusion weighted sequence of magnetic resonance imaging. The diagnostic digital subtraction angiography (DSA) was arranged during the hospitalization to gauge the degree of the carotid stenosis. The patients were stented one month after the index episode (stroke event). The participants were administered extracranial carotid ultrasound and CT angiography/perfusion (CTA/P) scanning simultaneously before carotid stenting. The above mentioned examinations were repeated simultaneously one month after stenting. This study was approved by the Institutional Review Board of Changhua Christian Hospital.

2.2. Baseline Clinical Characteristics {#sec2.2}
--------------------------------------

Baseline demographic data and clinical characteristics were collected including age, gender, and body mass index (BMI); baseline biochemistry data were collected on admission, such as low density lipoprotein (LDL) and glycated hemoglobin (HbA1c) levels and evidence or any major past history. Performance in activities of daily living was measured before stenting with the Barthel Index.

2.3. Cervical Carotid Ultrasound Examination {#sec2.3}
--------------------------------------------

Cervical carotid artery examination was performed in our ultrasonography laboratory by using a Philips iE33 7-Mhz linear transducer. Patients slightly tilted their head contralaterally, and the transducer was placed on their necks. First, cross-sectional B-mode scanning and longitudinal screening were performed to identify and confirm intraluminal plaques, respectively. Peak systolic velocity (PSV), end diastolic velocity (EDV), and resistance index (RI) of the CCA, internal carotid artery (ICA), and external carotid artery (ECA) were measured. RI is given by PSV − EDV/PSV. The degree of carotid stenosis was calculated using the European Carotid Surgery Trial method \[[@B3]\].

2.4. Computed Tomography Angiography/Perfusion Scan (CTA/P Imaging) {#sec2.4}
-------------------------------------------------------------------

CTA examinations were performed using a second-generation dual-source CT scanner (SOMATOM Definition Flash, Siemens Healthcare, Forchheim, Germany). Perfusion data sets were postprocessed using a Siemens Multimodality Workplace Workstation (Siemens Medical, Germany), which calculated mean transit time (MTT), cerebral blood volume (CBV), cerebral blood flow (CBF), and time to peak (TTP). The arterial input and venous outflow curves were analyzed to ensure data set completeness. The CTP parameters are defined as follows:dMTT: ipsilateral MTT − contralateral MTT.MTT ratio: ipsilateral MTT/contralateral MTT.MTT index: (ipsilateral MTT − contralateral MTT)/contralateral MTT.dCBV: ipsilateral CBV − contralateral CBV.CBV ratio: ipsilateral CBV/contralateral CBV.CBV index: (ipsilateral CBV − contralateral CBV)/contralateral CBV.dCBF: ipsilateral CBF − contralateral CBF.CBF ratio: ipsilateral CBF/contralateral CBF.CBF index: (ipsilateral CBF − contralateral CBF)/contralateral CBF.dTTP: ipsilateral TTP − contralateral TTP.TTP ratio: ipsilateral TTP/contralateral TTP.TTP index: (ipsilateral TTP − contralateral TTP)/contralateral TTP.

2.5. Magnetic Resonance Imaging and Angiography (MRI/A) {#sec2.5}
-------------------------------------------------------

Structural and functional MR imaging and angiographic examinations were performed using a 3-T (Magnetom Verio, Siemens Healthcare, USA) or a 1.5-T imager (Magnetom Aera, Siemens Healthcare) with a cervical coil. Standard protocol to evaluate a stroke including axial DWI, apparent diffusion coefficient, and fluid-attenuated inversion-recovery sequences was followed. Contrast-enhanced MR angiography was not routinely performed.

2.6. Digital Subtraction Angiography (DSA) and Stenting {#sec2.6}
-------------------------------------------------------

Biplanar intra-arterial DSA was performed using a biplanar flap panel rotational angiography unit (Axiom Artis Zee, Siemens Healthcare) with an image intensifier matrix of 1024 × 1024 pixels and a final pixel size of 0.37 mm. A self-expandable carotid wallstent (7 mm × 30 mm) was delivered coaxially through the guiding catheter into the stenotic area ([Figure 1](#fig1){ref-type="fig"}).

2.7. Statistical Analyses {#sec2.7}
-------------------------

Continuous variables are presented as mean ± standard deviation (SD), median, percentile, minimal, and maximal values. Categorical variables are presented as numbers and percentages. Pre- and poststenting CT perfusion and carotid ultrasound variables were compared using Wilcoxon signed ranks test. *P* \< 0.05 was considered statistically significant. All statistical analyses were performed using SPSS for Windows (Version 16.0, SPSS Inc., Chicago, IL, USA).

3. Results {#sec3}
==========

The baseline clinical characteristics of the 15 patients are summarized in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"} report the flow changes reflected by the parameters of CT perfusion and carotid ultrasound examinations.

Ipsilateral mean values of MTT, CBV, and TTP decreased after stenting, whereas CBF increased slightly. The majority of patients exhibited decreased MTT, CBV, and TTP. Pre- and posttreatment TTP values differed significantly (*P* = 0.031, \<0.05). Contralateral MTT, CBV, and TTP decreased, whereas the mean CBF increased slightly. The ratio of patients exhibiting decreased and increased contralateral MTT, CBV, CBF, and TTP values is approximately 1 ([Table 3](#tab3){ref-type="table"}).

Ipsilateral RI analyses showed that mean CCA RI reduced from 0.78 to 0.75, and most patients exhibited decreased CCA RIs. By contrast, mean ICA RI increased from 0.62 to 0.69, and most patients exhibited increased ICA RIs. Mean ECA RI decreased from 0.84 to 0.80; there are five and six patients, demonstrating decreased and increased ECA RIs, respectively ([Table 3](#tab3){ref-type="table"}).

Contralateral RI analyses revealed that CCA, ICA, and ECA RIs increased after stenting, with most patients showing increased mean CCA and ICA values; CCA RI increased from 0.73 to 0.77, ICA RI increased from 0.67 to 0.70, and ECA increased from 0.87 to 0.88 ([Table 3](#tab3){ref-type="table"}).

The mean values of all other 12 CT perfusion scan parameters ([Table 4](#tab4){ref-type="table"}) decreased after stenting. The majority of patients showed decreased values. Among the 12 parameters, MTT ratio, MTT index, and TTP ratio decreased significantly (*P* = 0.013, 0.039, and 0.017, \<0.05).

4. Discussion {#sec4}
=============

Stroke is the fourth leading cause of death worldwide \[[@B1], [@B2]\], and, among its various etiologies, carotid stenosis accounts for the majority of strokes. Carotid stenting can effectively prevent stroke and its recurrence.

CT perfusion is a standard assessment routinely performed before carotid stenting because it provides vivid color images and several parameters that clarify the ipsilateral and contralateral cerebral hemispheres perfusion status, as well as identifying stroke location \[[@B4]--[@B9]\]. However, not all patients can undergo this assessment tool. This is because they entail the use of contrast mediums, which is hazardous to patients with impaired renal function. In addition, CT perfusion administration is restricted to medical facilities, thus requiring patients to visit the facility. Moreover, it requires multiple operators, making it time intensive and expensive for patients.

By contrast, carotid duplex is a mobile, single-operator, contrast-medium-free, and inexpensive examination. Although no studies have examined the role of RI in evaluating cerebral perfusion status after carotid stenting, RI has been widely used in nephrology. Derchi et al. tested RI in patients with renal dysfunction and reported that the risk of renal impairment increased twofold when renal RI was \>0.63 \[[@B10]\]. In addition, RI is effective in predicting kidney transplant outcomes \[[@B11]--[@B13]\].

CT perfusion, by convention, is used to assess the cerebral artery perfusion status. The improvement of cerebral blood perfusion after stenting treatment can be indicated by a reduced MTT and an incased CBF within the ipsilateral carotid system \[[@B14], [@B15]\]. Our study is in accordance with these statements. The findings of MTT and CBF over the contralateral carotid system in the published papers \[[@B2], [@B16]\], however, have not come to general consensus. Our study shows that the MTT and CBF values decreased after treatment. Moreover, the absolute difference, ratio, and index values of bilateral cerebral hemispheres are also calculated. The results show a drop in values, particularly within the MTT ratio, MTT index, and TTP ratio.

RI, a clinical parameter generated from carotid ultrasounding, represents the general downstream blood vascular bed resistance level \[[@B17]\]. RI \> 0.75 denotes increased downstream vascular bed, which can be due to various factors, including obstructions. Because CCA and ICA supply the majority of blood to the intracranial hemispheres, their RI values are lower than that of ECA in normal circumstances (CCA and ICA \< 0.75, ECA \> 0.75).

In our study, ipsilateral mean CCA RI values decreased from 0.78 to 0.75 after carotid treatment, indicating that ICA flow smoothened and resistance level decreased after treatment, subsequently drawing more blood to perfuse the same side of the cerebral hemisphere. The mean ipsilateral ICA RI value, however, rose from 0.62 to 0.69, elucidating the vasoconstriction mechanism after upstream dilation. Nevertheless, ipsilateral CCA and ICA returned to their normal values (\<0.75). Conversely, on the contralateral side of the carotid system, mean RI rose in all carotid arteries (CCA, CA, and ECA), which explains the relatively low blood flow to the contralateral side of the vasculature because most of the blood was supplied to the ipsilateral side after stenting ([Figure 2](#fig2){ref-type="fig"}).

Our study has a few limitations. First, with only 15 patients, the sample size is small; the results must be interpreted cautiously, and additional studies are necessary for confirming their applicability in various other conditions. Second, the carotid duplex and CT perfusion scans were conducted during peristenting phases. Although the immediate effect of stenting can be detected, the long-term cerebral perfusion status is yet to be investigated. Finally, all participants in this study were of Asian origin; therefore, the results can be generalized only to an Asian population.

5. Conclusions {#sec5}
==============

The findings of our RI study on carotid ultrasounding and CT perfusion scanning can provide important clinical information in evaluating the perfusion status in patients receiving stenting, especially if the patient condition is not suitable for repeated CT perfusion examinations.
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###### 

The standard protocol of computed tomography angiography/perfusion, magnetic resonance imaging and angiography, along with digital subtraction angiography for carotid stenting procedure of Changhua Christian Hospital.
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![An example of left side severe internal carotid artery stenosis undergoing carotid stenting treatment. An 85-year-old male patient presented with right side hemiparesis and aphasia 24 hours before admission to our neurology ward. (i) (a) denotes CTA scan showing \>70% lumen reduction of left side proximal internal carotid artery and distal part of common carotid artery (black arrow). (ii) (b) shows the CT perfusion scan that suggests decreased blood perfusion to the left cerebral hemisphere indicating critical blood flow demand compared to the right side cerebral hemisphere. (iii) (c) presents the poststenting status with umbrella device that prevent embolus distal migration causing major subsequent stroke event (black arrow). (iv) (d) displays the follow-up cervical carotid ultrasound of normalized flow profile.](BMRI2016-7051856.001){#fig1}

![RI and flow changes of the patients receiving carotid stenting treatment. RI changes within ipsilateral and contralateral carotid systems. Red color denotes increased blood flow and blue color decreased flow.](BMRI2016-7051856.002){#fig2}

###### 

Baseline patient features.

  (*n* = 15)          Mean     SD      Median   Percentile 25   Percentile 75   Min      Max
  ------------------- -------- ------- -------- --------------- --------------- -------- --------
  Age                 66.47    9.59    69.00    56.00           73.00           47.00    79.00
  Grade of stenosis   0.71     0.10    0.74     0.67            0.78            0.53     0.84
  SBP                 137.27   10.73   138.00   128.00          149.00          118.00   155.00
  DBP                 77.47    8.33    80.00    74.00           84.00           62.00    90.00
  Weight              64.36    10.22   63.50    55.00           68.50           48.00    86.00
  Height              163.47   8.33    165.00   162.00          170.00          144.00   172.00
  BMI                 24.09    3.36    23.56    20.78           28.20           18.34    29.07
  Barthel             87.50    10.14   87.50    80.00           100.00          75.00    100.00
  LDL                 121.14   29.41   121.00   97.90           134.00          86.40    175.00
  HbA1c               6.94     1.89    6.65     5.70            7.30            5.30     12.60
  Ac sugar            119.67   46.18   96.00    94.00           128.00          80.00    227.00
  Uric acid           6.25     1.43    6.35     5.40            7.00            4.10     9.20

*Note*. Min, minimum; Max, maximum; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; LDL, low density lipoprotein; SD, standard deviation.

HbA1c, glycated hemoglobin; AC sugar, fasting blood sugar.

###### 

Baseline patient demographics.

                      *N*   \%
  ------------------- ----- ------
  Gender                     
   Female             2     13.3
   Male               13    86.7
  Diabetes mellitus          
   No                 6     40.0
   Yes                9     60.0
  Hypertension               
   No                 3     20.0
   Yes                12    80.0
  Hyperlipidemia             
   No                 4     26.7
   Yes                11    73.3
  Prior stroke               
   No                 8     53.3
   Yes                7     46.7

###### 

Changes in carotid duplex and CT perfusion parameters after carotid stenting.

                    (*n* = 15)         Ipsilateral   Contralateral                                                                                                                                                         
  ----------------- ------------------ ------------- --------------- ------- ------- ------- ------- ------- ------- --- --- ------- ---- ------- ------- ------- ------- ------- ------- -------- ------- --- --- ------- ---
  MTT               Before treatment   13            7.06            3.33    6.27    4.29    10.16   3.28    13.06                        13      5.74    2.93    5.05    3.59    7.77    3.05     12.07                    
  After treatment   13                 5.46          4.32            3.74    3.51    5.58    3.09    18.66   10      3   0   0.101   13   4.78    2.34    4.15    3.27    5.44    3.16    11.81    7       6   0   0.382   
                                                                                                                                                                                                                           
  CBF               Before treatment   15            39.89           17.15   42.56   24.50   56.93   13.93   61.56                        15      41.62   18.84   38.74   24.41   58.96   11.46    76.91                    
  After treatment   15                 40.65         14.01           39.74   34.90   48.08   5.17    62.60   8       7   0   1.000   15   43.56   20.40   40.78   35.57   47.89   7.86    106.83   7       8   0   0.776   
                                                                                                                                                                                                                           
  CBV               Before treatment   15            3.02            0.61    2.93    2.66    3.38    1.98    4.39                         15      3.00    1.17    3.01    1.96    3.32    1.73     5.79                     
  After treatment   15                 2.63          1.23            2.33    2.15    2.87    1.57    6.73    11      4   0   0.061   15   2.62    1.02    2.38    2.26    2.60    1.38    5.91     9       6   0   0.211   
                                                                                                                                                                                                                           
  TTP               Before treatment   15            18.89           10.50   12.78   10.08   28.65   8.44    39.28                        15      17.91   10.21   10.66   9.22    26.85   8.76     35.30                    
  After treatment   15                 12.17         4.13            11.12   9.32    12.70   9.18    23.60   11      4   0   0.031   15   12.50   2.80    11.71   10.82   13.57   9.72    21.03    9       6   0   0.307   
                                                                                                                                                                                                                           
  CCA RI            Before treatment   12            0.78            0.14    0.80    0.71    0.89    0.43    0.92                         13      0.73    0.06    0.75    0.69    0.77    0.60     0.82                     
  After treatment   12                 0.75          0.08            0.76    0.76    0.79    0.55    0.88    8       2   2   0.202   13   0.77    0.09    0.76    0.74    0.83    0.64    0.92     4       7   2   0.075   
                                                                                                                                                                                                                           
  ICA RI            Before treatment   12            0.62            0.19    0.62    0.52    0.73    0.24    0.91                         11      0.67    0.10    0.70    0.56    0.75    0.52     0.84                     
  After treatment   12                 0.69          0.10            0.70    0.60    0.76    0.58    0.89    3       7   2   0.103   11   0.70    0.07    0.69    0.63    0.78    0.57    0.81     3       7   1   0.220   
                                                                                                                                                                                                                           
  ECA RI            Before treatment   13            0.84            0.12    0.85    0.80    0.91    0.53    1.00                         13      0.87    0.11    0.90    0.80    0.96    0.61     1.00                     
  After treatment   13                 0.80          0.25            0.85    0.79    0.94    0.00    1.00    5       6   2   0.893   13   0.88    0.09    0.91    0.81    0.96    0.75    1.00     6       6   1   0.409   

*Note*. SD, standard deviation; CCA, common carotid artery; ICA, internal carotid artery; ECA, external carotid artery; RI, resistance index; MTT, mean transit time; CBF, cerebral blood flow; CBV, cerebral blood volume; TTP, time to peak.

*Q* ~1~: percentile 25; *Q* ~3~: percentile 75.

  ^a^ *P* value by Wilcoxon signed ranks test.

###### 

CT perfusion parameters before and after stenting.

              Time                                                                                                                             
  ----------- ------ ------- ------- ------ ------ ------- ------ ------- ---- ------ ------- ------ ------ ------ ------ ------- ---- --- --- -------
  MTT ratio   13     1.33    0.50    1.19   1.04   1.76    0.44   2.27    13   1.10   0.40    1.01   0.80   1.35   0.65   2.06    11   2   0   0.013
  dMTT        13     2.43    2.37    1.64   0.56   3.53    0.03   7.30    13   1.59   1.92    0.74   0.35   2.30   0.03   6.85    9    3   1   0.182
  MTT index   13     0.44    0.41    0.29   0.12   0.76    0.01   1.27    13   0.29   0.29    0.23   0.09   0.41   0.01   1.06    11   2   0   0.039
                                                                                                                                               
  CBV ratio   15     1.11    0.36    1.04   0.92   1.28    0.50   1.99    15   1.01   0.20    0.98   0.86   1.14   0.64   1.42    9    6   0   0.394
  dCBV        15     0.72    0.77    0.41   0.18   0.97    0.12   2.89    15   0.39   0.29    0.35   0.19   0.45   0.03   0.95    9    6   0   0.191
  CBV index   15     0.26    0.26    0.14   0.06   0.49    0.04   0.99    15   0.15   0.12    0.14   0.08   0.20   0.01   0.42    9    6   0   0.334
                                                                                                                                               
  CBF ratio   15     1.13    0.76    0.89   0.72   1.47    0.32   3.53    15   0.97   0.27    0.96   0.83   1.11   0.58   1.68    8    7   0   0.910
  dCBF        15     13.91   15.00   8.54   5.69   18.19   1.26   52.41   15   9.13   11.97   5.10   2.69   6.94   1.32   44.94   10   5   0   0.100
  CBF index   15     0.44    0.62    0.28   0.11   0.51    0.02   2.53    15   0.20   0.18    0.13   0.05   0.34   0.03   0.68    9    6   0   0.156
                                                                                                                                               
  TTP ratio   15     1.08    0.18    1.01   0.97   1.32    0.79   1.37    15   0.96   0.14    0.92   0.86   1.04   0.78   1.26    12   3   0   0.017
  dTTP        15     2.10    2.19    0.96   0.29   3.39    0.17   7.02    15   1.62   1.12    1.50   0.54   2.53   0.17   3.90    8    7   0   0.532
  TTP Index   15     0.14    0.14    0.09   0.02   0.32    0.01   0.37    15   0.12   0.08    0.12   0.06   0.21   0.01   0.26    6    9   0   0.910

*Note*. SD, standard deviation; dMTT, difference of mean transit time; dCBV, difference of cerebral blood volume; dCBF, difference of cerebral blood flow; dTTP, difference of time to peak.

*Q* ~1~: percentile 25; *Q* ~3~: percentile 75.

*P* value by Wilcoxon signed ranks test.
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